| Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687) |
|---|
| 03/21/2006 | US7015216 Heteroaryl-β-alanine derivatives as alpha 4 integrin inhibitors |
| 03/21/2006 | CA2242416C Sulfonated amino acid derivatives and metalloproteinase inhibitors containing the same |
| 03/21/2006 | CA2238816C N-acyl-2-substituted-4-(benzimidazolyl- or imidazopyridinyl-substituted residues)-piperidines as tachykinin antagonists |
| 03/21/2006 | CA2212466C Calcium specific diaza-18-crown-6-ether chromoionophores |
| 03/21/2006 | CA2183250C Prodrugs of morpholine tachykinin receptor antagonists |
| 03/21/2006 | CA2178949C Morpholine and thiomorpholine tachykinin receptor antagonists |
| 03/21/2006 | CA2134625C Substituted pyridylsalicylaldehyde or -salicylic acid derivatives, their preparation and their use as herbicides |
| 03/21/2006 | CA2124932C Sex steroid activity inhibitors |
| 03/16/2006 | WO2006028958A2 Pyridyl inhibitors of hedgehog signalling |
| 03/16/2006 | WO2006028957A1 4-substituted 4, 6-dialkoxy-cinnoline derivatives as phospodiesterase 10 inhibitors for the treatment of psychiatric or neurological syndroms |
| 03/16/2006 | WO2006028290A1 2-morpholino-4-pyrimidone compound |
| 03/16/2006 | WO2006028284A1 Morpholine compound |
| 03/16/2006 | WO2006027628A2 Naphthalimide derivatives as antiviral agents |
| 03/16/2006 | WO2006027211A1 2,4-substituted pyrimidines as cysteine protease inhibitors |
| 03/16/2006 | WO2005123680B1 Six-membered heterocycles useful as serine protease inhibitors |
| 03/16/2006 | WO2005121121A3 Substituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto |
| 03/16/2006 | WO2005113535A3 Pyrazinylmethyl lactam derivatives |
| 03/16/2006 | WO2005113494A3 Nitrogenated heterocyclic derivatives as protein kinase modulators and use for the treatment of angiogenesis and cancer |
| 03/16/2006 | WO2005111008A3 Compounds for enzyme inhibition |
| 03/16/2006 | WO2005077344A3 Hydantoin derivatives as inhibitors of cellular necrosis |
| 03/16/2006 | US20060058522 2-[(aminocarbonyl)amino]-5-(4-{[2,2,2-trifluoroethyl)amino]methyl}phenyl)thiophene-3-carboxamide; I kappa B kinase-1(IKK-1) inhibitors; asthma, rheumatoid arthritis, psoriasis, inflammatory bowel disease, multiple sclerosis, chronic obstructive pulmonary disease, bone resorptive disease, osteoarthritis |
| 03/16/2006 | US20060058353 Benzofuran derivatives, process for their preparation and intermediates thereof |
| 03/16/2006 | US20060058351 Novel ligands that modulate LXR-type receptors and cosmetic/pharmaceutical applications thereof |
| 03/16/2006 | US20060058349 Piperidinetriol derivatives as inhibitors of glycosyceramid synthase |
| 03/16/2006 | US20060058346 Novel enantiomers of etrahydroisoquinoline derivatives and theirpharmaceutically acceptable salts, their preparations and pharmaceutical compositions |
| 03/16/2006 | US20060058317 Oxazolidinone derivatives as antibacterial |
| 03/16/2006 | US20060058314 Oxazolidinone derivatives and their use as antibacterial agents |
| 03/16/2006 | US20060058309 Respiratory syncytial virus replication inhibitors |
| 03/16/2006 | US20060058294 Carboxamidine derivatives and their use in the treatment of vascular diseases |
| 03/16/2006 | US20060058292 2,4-pyrimidinediamine compounds and their uses |
| 03/16/2006 | US20060058291 Cyclic oxyguanidine pyrazinones as protease inhibitors |
| 03/16/2006 | US20060058289 Mercaptoimidazoles as ccr2 receptor antagonists |
| 03/16/2006 | US20060058285 Substituted 4-(4-piperidin-4-yl-piperazin-1-yl)-azepane derivatives and their use as neurokinin antagonists |
| 03/16/2006 | CA2578996A1 4-substituted 4, 6-dialkoxy-cinnoline derivatives as phospodiesterase 10 inhibitors for the treatment of psychiatric or neurological syndroms |
| 03/16/2006 | CA2578434A1 2-morpholino-4-pyrimidone compound |
| 03/15/2006 | EP1634876A2 Heterocyclic compounds for the treatment of hyperlipidemia agents |
| 03/15/2006 | EP1633771A1 Macrolide-conjugates with anti-inflammatory activity |
| 03/15/2006 | EP1633746A1 New indole derivatives as factor xa inhibitors |
| 03/15/2006 | EP1633745A1 Aroyl semicarbazide derivatives against thromboembolic diseases |
| 03/15/2006 | EP1633743A1 Cyclic amine derivatives and their use in the treatment of inflammation-related disorders mediated by bradykinin |
| 03/15/2006 | EP1633740A2 Chemical compounds |
| 03/15/2006 | EP1633735A1 Derivatives of piperidinyl- and piperazinyl-alkyl carbamates, preparation methods thereof and application of same in therapeutics |
| 03/15/2006 | EP1633732A1 Benzyl sulfonamide derivatives as androgen receptor antagonists |
| 03/15/2006 | EP1633730A1 N-alkynyl-2-heteroaryloxyalkylamides for use as fungicides |
| 03/15/2006 | EP1633729A1 Sulphonamide compounds that modulate chemokine receptor activity (ccr4) |
| 03/15/2006 | EP1633725A1 Hepatitis c virus inhibitors |
| 03/15/2006 | EP1633724A1 Phthalazinone derivatives |
| 03/15/2006 | EP1633722A2 Preparation and use of aryl alkyl acid derivatives for the treatment of obesity |
| 03/15/2006 | EP1633717A1 New p2x7 receptor antagonists and their use |
| 03/15/2006 | EP1633710A1 Isoindolin-1-one compounds as kinase inhibitors |
| 03/15/2006 | EP1633352A1 Polyene oxazoles with antitumour activity and processes for their preparation using a streptomyces strain |
| 03/15/2006 | EP1633349A1 4-bromo-5- (2-chloro-benzoylamino)-1h-pyrazole-3-carboxylic acid (1-(aminocarbonyl) eth-1-yl) amide derivatives and related compounds as bradykinin b1 receptor antagonists for the treatment of inflammatory diseases |
| 03/15/2006 | EP1633348A1 4- BROMO - 5 - (2- CHLORO - BENZOYLAMINO) - 1H - PYRAZOLE - 3 - CARBOXYLIC ACID AMIDE DERIVATIVES AND RELATED COMPOUNDS AS BRADYKININ B sb 1 /sb RECEPTOR ANTAGONISTS FOR THE TREATMENT OF INFLAMMATORY DISEASES |
| 03/15/2006 | EP1633346A1 Pyrrolidin-1, 2- dicarboxylic acid- 1- (4- ethinyl- phenyl) - amid]- 2- (phenyl)- amid] derivative as inhibitors of coagulation factor xa and viia for the treatment of thrombosis |
| 03/15/2006 | EP1633343A1 3-aminomethyl-pyrrolidines as n-type calcium channel blockers |
| 03/15/2006 | EP1465864B1 Inhibitors of factor xa and other serine proteases involved in the coagulation cascade |
| 03/15/2006 | EP1408962B1 Substituted isoindoles and the use thereof |
| 03/15/2006 | EP1326864B1 Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents |
| 03/15/2006 | EP1309593B1 Substituted pyrazoles |
| 03/15/2006 | CN1747951A Novel 2-pyridinecarboxamide derivatives |
| 03/15/2006 | CN1747942A Heterocyclic compounds useful as nurr-1 activators |
| 03/15/2006 | CN1747940A Crystalline modifications of triazinylaminostilbenes |
| 03/15/2006 | CN1747936A Substituted azole derivatives as therapeutic agents |
| 03/15/2006 | CN1747732A 2-aminocarbonyl-quinoline compounds as platelet adenosine diphosphate receptor antagonists |
| 03/15/2006 | CN1245401C 6-aryl-4-aminopicolinates and their use as herbicides |
| 03/15/2006 | CN1245400C N-substituted benzothiophenesulfonamide derivatives |
| 03/15/2006 | CN1245386C 1,2-dihydropyridine compounds, process for preparation of same and use thereof |
| 03/15/2006 | CN1245385C Indole and dihydroindole derivatives |
| 03/15/2006 | CN1245155C Oral pharmaceutical pulsed release dosage form |
| 03/14/2006 | US7012146 Modulators of all three classes of calcium channel blocker subtypes (Small, Intermediate and Big conductance K channel (SK, IK and BK)) comprising malonate esters and nitriles; respiratory, brain, cardiovascular, urogenital disorders |
| 03/14/2006 | US7012094 such as 3-(4-fluorophenyl)-4-(methylsulfonylphenyl)furan; for treatment of arthritis |
| 03/14/2006 | US7012088 Indolone oxazolidinones and derivatives thereof |
| 03/14/2006 | US7012085 As antipsychotics in therapy of schizophrenia, depression, bipolar disorders, cognition deficits, Parkinson disease, drug abuse, attention deficit hyperactivity disorders, glaucoma, diabetes and erectile dysfunction |
| 03/14/2006 | US7012084 Acylated piperidine derivatives as melanocortin-4 receptor agonists |
| 03/14/2006 | US7012075 Cathepsin cysteine protease inhibitors |
| 03/14/2006 | CA2359363C 4-(heterocyclylsulfonamido)-5-methoxy-6-(2-methoxyphenoxy)-2-phenyl- or pyridylpyrimidines as endothelin receptor antagonists |
| 03/14/2006 | CA2278241C Phenyl heterocycles as cyclooxygenase-2 inhibitors |
| 03/14/2006 | CA2267879C Heteroaryl succinamides and their use as metalloproteinase inhibitors |
| 03/14/2006 | CA2239547C Benzazepine derivatives with vasopressin agonistic activity |
| 03/09/2006 | WO2006026204A2 Novel gamma-lactams as beta-secretase inhibitors |
| 03/09/2006 | WO2006026033A2 Novel chalcogenoxanthylium dyes for purging blood pathogens and for photodynamic therapy |
| 03/09/2006 | WO2006025979A2 Modulators of nuclear receptors |
| 03/09/2006 | WO2006025471A1 Piperidine derivative or pharmaceutically acceptable salt thereof |
| 03/09/2006 | WO2006024820A1 Isoxazoline derivatives and their use as herbicides |
| 03/09/2006 | WO2005097751A3 Non-imidazole heterocyclic compounds as histamine h3-receptor ligands |
| 03/09/2006 | US20060052605 1,4-disubstituted piperazine compounds; for example 2-{4-[2-(acetylamino)-3-(2-methylbenzothiazol-5-yloxy)propyl]piperazinyl}-N-(3-phenylphenyl)acetamide; cardiovascular diseases such as arrhythmias, intermittent claudication, angina, congestive heart disease, diabetes, and myocardial infarction |
| 03/09/2006 | US20060052597 Aryloxyalkylamine derivatives as h3 receptor ligands |
| 03/09/2006 | US20060052595 Heterocyclic compounds as ccr5 antagonists |
| 03/09/2006 | US20060052491 Synergistic uv absorber combination |
| 03/09/2006 | US20060052423 Peptide deformylase inhibitors |
| 03/09/2006 | US20060052415 N-{2-chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]phenyl}-n'-(5-methyl-3-isoxazolyl)urea salt in crystalline form |
| 03/09/2006 | US20060052411 Immunosuppressants, analgesics, antiinflammatory agents |
| 03/09/2006 | US20060052408 Cyclopropyl compounds as ccr5 antagonists |
| 03/09/2006 | US20060052399 Oxazolidinone derivatives as antibacterial agents |
| 03/09/2006 | US20060052395 N-(3,5-diamino-6-chloropyrazine-2-carbonyl)-N'-(4-{4-[3-(1H-tetrazol-5-yl)propoxy]phenyl}butyl)guanidine hydrochloride; hydrates mucosal surfaces; are absorbed less rapidly, thus have a prolonged pharmacodynamic half-life; skin and respiratory disorders, vision deffects |
| 03/09/2006 | US20060052394 N-(3,5-diamino-6-chloropyrazine-2-carbonyl)-N'-(4-{4-[3-(1H-tetrazol-5-yl)propoxy]phenyl}butyl)guanidine hydrochloride; hydrates mucosal surfaces; are absorbed less rapidly, thus have a prolonged pharmacodynamic half-life; skin and respiratory disorders, vision deffects |
| 03/09/2006 | US20060052384 Aryl piperidine derivatives as inducers of ldl-receptor expression for the treatment of hypercholesterolemia |
| 03/09/2006 | US20060052376 Carboxamides |
| 03/09/2006 | US20060052375 Bis-alkylbenzylamines |
| 03/09/2006 | US20060052374 Amino-tetrazole analogues and methods of use |